title: Is azole resistance in Aspergillus fumigatus a problem in Spain?
abstract: Aspergillus fumigatus complex comprises A. fumigatus and other morphologically indistinguishable cryptic species. We retrospectively studied 362 A. fumigatus complex isolates (353 samples) from 150 patients with proven or probable invasive aspergillosis or aspergilloma (2, 121, and 6 samples, respectively) admitted to the hospital from 1999 to 2011. Isolates were identified using the β-tubulin gene, and only 1 isolate per species found in each sample was selected. Antifungal susceptibility to azoles was determined using the CLSI M38-A2 procedure. Isolates were considered resistant if they showed an MIC above the breakpoints for itraconazole, voriconazole, or posaconazole (>2, >2, or >0.5 μg/ml). Most of the samples yielded only 1 species (A. fumigatus [n = 335], A. novofumigatus [n = 4], A. lentulus [n = 3], A. viridinutans [n = 1], and Neosartorya udagawae [n = 1]). The remaining samples yielded a combination of 2 species. Most of the patients were infected by a single species (A. fumigatus [n = 143] or A. lentulus [n = 2]). The remaining 5 patients were coinfected with multiple A. fumigatus complex species, although A. fumigatus was always involved; 4 of the 5 patients were diagnosed in 2009 or later. Cryptic species were less susceptible than A. fumigatus. The frequency of resistance among A. fumigatus complex and A. fumigatus to itraconazole, voriconazole, and posaconazole was 2.5 and 0.3%, 3.1 and 0.3%, and 4.2 and 1.8%, respectively, in the per-isolate analysis and 1.3 and 0.7%, 2.6 and 0.7%, and 6 and 4% in the per-patient analysis. Only 1 of the 6 A. fumigatus isolates in which the cyp51A gene was sequenced had a mutation at position G448. The proportion of patients infected by azole-resistant A. fumigatus isolates was low.
authors: Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense de Madrid, Madrid, Spain.
authors: Pilar
authors: P
authors: Escribano
authors: Teresa
authors: T
authors: Peláez
authors: Patricia
authors: P
authors: Muñoz
authors: Emilio
authors: E
authors: Bouza
authors: Jesús
authors: J
authors: Guinea
mesh_terms: D000935:Antifungal Agents / Q000145:classification / Q000494:pharmacology* / Q000627:therapeutic use; D001228:Aspergillosis / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology; D001232:Aspergillus fumigatus / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification; D001393:Azoles / Q000145:classification / Q000494:pharmacology* / Q000627:therapeutic use; D025141:Drug Resistance, Fungal; D005260:Female; D005656:Fungal Proteins / Q000235:genetics; D006784:Hospitals, Teaching; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests / Q000379:methods; D009154:Mutation; D013030:Spain / Q000453:epidemiology; D014404:Tubulin / Q000235:genetics
chemical_list: D000935:Antifungal Agents; D001393:Azoles; D005656:Fungal Proteins; D014404:Tubulin
references: Drug Resist Updat. 2009 Dec;12(6):141-7
references: 19879181
references: J Clin Microbiol. 2003 Sep;41(9):4101-6
references: 12958232
references: N Engl J Med. 2007 Jan 25;356(4):348-59
references: 17251531
references: Antimicrob Agents Chemother. 2012 Feb;56(2):869-74
references: 22123701
references: Antimicrob Agents Chemother. 2011 Jul;55(7):3564-6
references: 21502625
references: J Clin Microbiol. 2009 Jul;47(7):2079-83
references: 19403766
references: Antimicrob Agents Chemother. 2006 Jun;50(6):2009-15
references: 16723559
references: Antimicrob Agents Chemother. 2003 Mar;47(3):1120-4
references: 12604551
references: Am J Transplant. 2009 Dec;9 Suppl 4:S180-91
references: 20070679
references: J Clin Microbiol. 2011 Jun;49(6):2243-51
references: 21508152
references: Antimicrob Agents Chemother. 2010 Nov;54(11):4545-9
references: 20805399
references: Antimicrob Agents Chemother. 2011 May;55(5):2460-2
references: 21321141
references: Antimicrob Agents Chemother. 2005 Aug;49(8):3495-7
references: 16048968
references: J Med Microbiol. 2013 Mar;62(Pt 3):474-478
references: 23161769
references: Antimicrob Agents Chemother. 2004 Jul;48(7):2747-50
references: 15215142
references: J Antimicrob Chemother. 2012 Feb;67(2):362-6
references: 22028200
references: Emerg Infect Dis. 2011 Oct;17(10):1846-54
references: 22000354
references: Antimicrob Agents Chemother. 2012 Jan;56(1):174-8
references: 22006000
references: J Clin Microbiol. 2009 Oct;47(10):3142-6
references: 19692559
references: Antimicrob Agents Chemother. 2011 Sep;55(9):4465-8
references: 21690285
references: Emerg Infect Dis. 2009 Jul;15(7):1068-76
references: 19624922
references: Antimicrob Agents Chemother. 2006 Mar;50(3):917-21
references: 16495251
references: Antimicrob Agents Chemother. 2012 Nov;56(11):6060-1
references: 22890769
references: J Clin Microbiol. 2009 Apr;47(4):877-84
references: 19073865
references: Lancet Infect Dis. 2009 Dec;9(12):789-95
references: 19926038
references: N Engl J Med. 2007 Apr 5;356(14):1481-3
references: 17409336
references: Haematologica. 2010 Apr;95(4):644-50
references: 19850903
references: Med Mycol. 2010 Feb;48(1):197-200
references: 20055745
references: N Engl J Med. 2002 Aug 8;347(6):408-15
references: 12167683
references: Eur Respir J. 2007 Oct;30(4):782-800
references: 17906086
references: Clin Infect Dis. 2009 Feb 1;48(3):265-73
references: 19115967
references: J Antimicrob Chemother. 2012 Aug;67(8):1870-3
references: 22581906
references: Eukaryot Cell. 2005 Mar;4(3):625-32
references: 15755924
references: J Clin Microbiol. 2010 Sep;48(9):3251-7
references: 20592159
references: J Antimicrob Chemother. 2010 Oct;65(10):2116-8
references: 20729241
references: Clin Infect Dis. 2010 Apr 15;50(8):1101-11
references: 20218876
references: Antimicrob Agents Chemother. 2012 Jan;56(1):10-6
references: 22005994
references: Med Mycol. 2006 Sep 1;44(Supplement_1):S1
references: 30408891
references: Appl Environ Microbiol. 2009 Jun;75(12):4053-7
references: 19376899
references: Scand J Infect Dis. 1997;29(5):509-12
references: 9435042
references: Int J Antimicrob Agents. 2006 Nov;28(5):450-3
references: 17034993
references: Clin Infect Dis. 2011 May;52(9):1123-9
references: 21467016
references: Eur J Clin Microbiol Infect Dis. 2011 Nov;30(11):1355-63
references: 21541671
references: Transpl Infect Dis. 2010 Jun;12(3):220-9
references: 20113459
references: Clin Infect Dis. 2010 Apr 15;50(8):1091-100
references: 20218877
references: J Clin Microbiol. 2012 Jul;50(7):2531-4
references: 22573589
references: Antimicrob Agents Chemother. 2007 Jun;51(6):1897-904
references: 17371828
references: Antimicrob Agents Chemother. 2012 Jan;56(1):584-7
references: 22024829
references: PLoS Med. 2008 Nov 11;5(11):e219
references: 18998768
references: Clin Infect Dis. 2008 Jun 15;46(12):1813-21
references: 18462102
references: Clin Microbiol Infect. 2010 Jul;16(7):870-7
references: 19906275
references: J Antimicrob Chemother. 2011 Feb;66(2):371-4
references: 21131690